Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Developmental role of macrophages modelled in human pluripotent stem cell derived intestinal tissue

PROVIDER: PRJNA890190 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21890791_1.fastq.gz	Fastqsanger.gz
	SRR21890791_2.fastq.gz	Fastqsanger.gz
	SRR21890792_1.fastq.gz	Fastqsanger.gz
	SRR21890792_2.fastq.gz	Fastqsanger.gz
	SRR21890793_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Homo sapiens

Project description:Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells

| PRJNA245172 | ENA

Homo sapiens

Project description:Human induced pluripotent stem cell-derived macrophages share ontogeny with MYB-independent tissue-resident macrophages

| PRJNA360466 | ENA

Metabolomic Profiling of Human Pluripotent Stem Cell Differentiation into Lung Progenitors

Project description:Metabolism is vital to cellular function and tissue homeostasis during human lung development. In utero, embryonic pluripotent stem cells undergo endodermal differentiation towards a lung progenitor cell fate that can be mimicked in vitro using induced human pluripotent stem cells (hiPSCs) to study genetic mutations. To identify differences between wild type and surfactant protein B (SFTPB)-deficient cell lines during endoderm specification towards lung, we used an untargeted metabolomics approach to evaluate the developmental changes in metabolites. We found that the metabolites most enriched during the differentiation from pluripotent stem cell to lung progenitor cell, regardless of cell line, were sphingomyelins and phosphatidylcholines, two important lipid classes in fetal lung development. The SFTPB mutation had no metabolic impact on early endodermal lung development. The identified metabolite signatures during lung progenitor cell differentiation may be utilized as biomarkers for normal embryonic lung development.

2021-06-29 | ST002055 | MetabolomicsWorkbench

Human pluripotent stem cell-derived macrophages host Mycobacterium abscessus infection

Project description:Human pluripotent stem cell-derived macrophages host Mycobacterium abscessus infection

| PRJNA762242 | ENA

Human pluripotent stem cell-derived macrophages host Mycobacterium abscessus infection

Project description:Human pluripotent stem cell-derived macrophages host Mycobacterium abscessus infection

| PRJNA855683 | ENA

scRNA-seq of pluripotent stem cell derived human intestinal organoids

Project description:scRNA-seq of pluripotent stem cell derived human intestinal organoids

| PRJEB43883 | ENA

Exploiting induced pluripotent stem cell-derived macrophages to unravel host factors influencing Chlamydia trachomatis pathogenesis

Project description:Chlamydia trachomatis remains a leading cause of bacterial sexually transmitted infections and preventable blindness worldwide. There are, however, limited in vitro models to study the role of host genetics in the response of macrophages to this obligate human pathogen. Here, we describe an approach using macrophages derived from human induced pluripotent stem cells (iPSdMs) to study macrophage-Chlamydia interactions in vitro. We show that iPSdMs support the full infectious life cycle of C. trachomatis in a manner that mimicks the infection of human blood-derived macrophages. Transcriptomic and proteomic profiling of the macrophage response to chlamydial infection highlights the role of the type I interferon and interleukin 10-mediated responses. Using CRISPR/Cas9 technology, we generate biallelic knockout mutations in the host genes encoding IRF5 and IL-10RA in iPSCs, confirming their roles in limiting chlamydial infection in macrophages. This model can potentially be extended to other pathogens and tissue systems to advance our understanding of host-pathogen interactions and the role of human genetics in influencing the outcome of infections.

2018-02-14 | PXD005858 | Pride

Proteomic signatures of schizophrenia-sourced iPSC-derived brain organoids

Project description:Schizophrenia is a complex and severe neuropsychiatric disorder, with a wide range of debilitating symptoms. Several aspects of its multifactorial complexity are still unknown, and some are accepted to be an early developmental deficiency with a more specifically neurodevelopmental origin. Understanding timepoints of disturbances during neural cell differentiation processes could lead to an insight into the development of the disorder. In this context, human brain organoids and neural cells differentiated from patient-derived induced pluripotent stem cells are of great interest as a model to study the developmental origins of the disease. Here we evaluated the differential expression of proteins of schizophrenia patient-derived neural progenitors, early neurons, and brain organoids. Using bottom-up shotgun proteomics with a label-free approach for quantitative analysis. Multiple dysregulated proteins were found in pathways related to synapses, in line with postmortem tissue studies of schizophrenia patients. However, organoids and immature neurons exhibit impairments in pathways never before found in patient-derived induced pluripotent stem cell studies, such as spliceosomes and amino acid metabolism. In conclusion, here we provide comprehensive, large-scale, protein-level data that may uncover underlying mechanisms of the developmental origins of schizophrenia.

2023-03-11 | PXD026381 | Pride

Proteomic signatures of schizophrenia-sourced iPSC-derived neural progenitors and neurons

2023-03-11 | PXD026593 | Pride

In vitro maturation of human pluripotent stem cell-derived intestinal organoids

Project description:In vitro maturation of human pluripotent stem cell-derived intestinal organoids

| PRJNA480018 | ENA